Click here to

Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.

3 | A | B | C | D | E | F | G | H | I | K | L | M | N | O | P | Q | R | S | T | U | V | X | show all

Keywords: intensity modulation
MO-EF-TRACK 4-7Latent Space Arc Therapy Optimization
N Bice1*, N Kirby1, D Nguyen2, C Kabat1, P Myers1, N Papanikolaou1, M Fakhreddine1, (1) UT Health San Antonio MD Anderson Cancer Center, San Antonio, Texas, (2) UT Southwestern Medical Center, Dallas, TX.
MO-IePD-TRACK 6-7Effective Organs-At-Risk Dose Sparing in Volumetric Modulated Arc Therapy Using a Half-Beam Technique in Whole Pelvic Irradiation
H Park1*, J Park2,3, M Artz2,3, Y Zhang2,3, J Ricci4, H Jang5, S Huh2,3, (1) Ajou University School of Medicine, Suwon, South Korea, (2) University of Florida College of Medicine, Gainesville, FL, (3) University of Florida Health Proton Therapy Institute, Jacksonville, FL, (4) Orlando Health UF Health Cancer Center, Orlando, FL, (5) Dongguk University College Of Medicine, Gyeongju, South Korea
PO-GePV-T-178An Improved Statistical Model for Gamma Index Pass Rates in Intensity Modulated Radiation Therapy Patient-Specific Quality Assurance
P. James Jensen*, William Donahue, Zhe Chen, Yale University School of Medicine, New Haven, CT
PO-GePV-T-212Evaluation of Elekta Unity IMRT Beam Complexity Using a Novel Leaf Sequencer and Shape Optimizer in the Monaco Treatment Planning System
J St-Aubin*, J Snyder, S Yaddanapudi, R Flynn, D Hyer, University of Iowa Hospitals and Clinics, Iowa City, IA
PO-GePV-T-233Dosimetric Comparison of VMAT Prostate Plans Designed with 10MV Vs 18MV Photon Beams
D Shvydka1, M Hajduk2*, (1) University of Toledo Health Science Campus, Toledo, OH, (2) ,University of Toledo Health Science Campus, Toledo, OH,
PO-GePV-T-263Evaluation of Treatment Plan Uncertainties for VMAT TBI
I Duarte*, P Galavis, N Gerber, D Barbee, J Teruel, NYU Langone Health, New York, NY
PO-GePV-T-316Modulation Area Index (MAI): A Plan-Specific Metric for Quantifying VMAT Modulation Complexity
B Wu*, R Gonzales, J Qian, L Lin, J Yu, H Li, S Han-Oh, Johns Hopkins University, Baltimore, MD
PO-GePV-T-386The Influence of Iso-Center Location, Beam Type and Lesion Size On Plan Specific QA in Lung SBRT
Shahram Mashouf, PhD*, Anderson Bauer, MD and Sugata Tripathi, PhD, Marshfield Clinic Health System, Marshfield, WI
PO-GePV-T-436Analysis of Preclinical IMRT Plan Quality Versus Number of Beam Angles
D Olivera Velarde1*, E Pearson1, B Aydogan1, H Halpern1, G Redler2, B Epel1, J Slagowski1, (1) University of Chicago, Chicago, IL, (2) H. Lee Moffitt Cancer Center, Tampa, FL
SU-IePD-TRACK 5-3Development of a Dynamic-Shield Applicator Enabling Intensity-Modulated Brachytherapy for the Treatment of Rectal Cancer
A Thibodeau-Antonacci1*, T Vuong2, H Bekerat1,2, L Liang1,2, S Abbasinejad Enger1,3, (1) McGill University, Montreal, QC, CA, (2) Jewish General Hospital, Montreal , QC, CA, (3) Lady Davis Institute, Montreal, Qc, CA.
SU-IePD-TRACK 5-5Integrating Rotatable Tandem Applicator to Conventional Ovoid Applicator for Complete Framework of Intensity Modulated Brachytherapy (IMBT) for Cervical Cancer
H Kim1*, Y Goh2, D Kim1, J Kim1, Y Lim3, (1) Department of Radiation Oncology,Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, ,KR, (2) Department of Radiation Oncology, Asan Medical Center, Seoul, Korea, KR (5) National Cancer Center, Goyang-si, ,KR
SU-IePD-TRACK 5-5Improved Dosimetric Performance of VMAT Total Marrow Irradiation Using Knowledge-Based Planning Approach
K Ahn1,2*, M Koshy1,2, J Partouche2, D Rondelli1, P Patel1, Y Hasan2, H Liu2, B Aydogan2, (1) University of Illinois at Chicago, Chicago, IL, (2) University of Chicago, Chicago, IL
TH-C-TRACK 5-7Commissioning of a Novel Compensator-Based IMRT System for Low- and Middle-Income Countries
K Oh*/The University of Washington and The University of Texas MD Anderson Cancer Center, B Sengupta/The University of Washington, A Olanrewaju/The University of Texas MD Anderson Cancer Center, R Douglas/The University of Texas MD Anderson Cancer Center, K Roach/The University of Texas MD Anderson Cancer Center, C Cardenas/The University of Texas MD Anderson Cancer Center, L Court/The University of Texas MD Anderson Cancer Center, E Ford/The University of Washington
TH-F-TRACK 4-4Head-And-Neck IMRT Auto-Planning Through Fluence Map Prediction Using Progressive Growing of Generative Adversarial Networks
X Li1*, QJ Wu1, Q Wu1, C Wang1, Y Sheng1, W Wang1, H Stephens1, F Yin1, Y Ge2, (1) Duke University Medical Center, Durham, NC, (2) University of North Carolina at Charlotte, Charlotte, NC
WE-C-TRACK 3-7Sensitivity Evaluation of Patient Specific Quality Assurance - Independent Assessment of Quality
J Lehmann1,2,3*, M Hussein4, S Siva5, A Moore3,6, T Standen1, B Subramanian7, P Greer1,3, CH Clark4,8,9, (1) Calvary Mater Newcastle Hospital, Newcastle, AU (2) University of Sydney, Sydney, AU (3) University of Newcastle, Newcastle, AU (4) National Physical Laboratory, Teddington, UK (5) Peter MacCallum Cancer Centre, Melbourne, AU (6) TROG Cancer Research, Newcastle, AU (7) GenesisCare, Bundoora, AU (8) University College London Hospital, London, UK (9) National Radiotherapy Trials Quality Assurance Group, London, UK